Truist Securities Downgrades Alexion Pharmaceuticals (ALXN) to Hold

December 16, 2020 4:29 AM EST Send to a Friend
Truist Securities analyst Robyn Karnauskas downgraded Alexion Pharmaceuticals (NASDAQ: ALXN) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login